1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Spironolactone not beneficial in heart failure with preserved ejection … – 2 Minute Medicine

April 9, 2014Organ Failureadmin

2 Minute Medicine

Spironolactone not beneficial in heart failure with preserved ejection ...
2 Minute Medicine
1. There was no significant difference in the primary composite outcome (death from cardiovascular causes, aborted cardiac arrest, and hospitalization for heart failure) between the spironolactone and placebo groups. 2. Post hoc analyses showed that ...

Post navigation

← Malignant Growth: Battling a New Cancer Pandemic – Inter Press Service Cytoreductive Nephrectomy in Untreated Metastatic RCC – OncLive →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos